2022 Developments in Cellular Therapy (Live)
Registration coming soon! 
Category
Format
  • Conference / meeting
Credits
Event date November 5, 2022
2022 Developments in Cellular Therapy (Virtual)
Registration coming soon! 
Category
Format
  • Conference / meeting
Credits
Event date November 5, 2022
2022 Developments in Cellular Therapy 20221105
Registration coming soon! 
Category
Format
  • Conference / meeting
Credits
  • AMA PRA Category 1 Credit
  • Attendance
Event date November 5, 2022
2022 Developments in Cellular Therapy Exhibit Registration
The exhibit payment portal will open on July 1, 2022. 
Category
Format
  • Conference / meeting
Credits
Event date November 5, 2022
41st Annual Internal Medicine Review 2022
This activity is designed to provide the internal medicine and primary care physician as well as the physician assistants and nurse practitioners with information directly applicable to daily patient care.
Category
Format
  • Hybrid
  • Conference / meeting
Credits
  • AMA PRA Category 1 Credit
  • Attendance
Event date July 11, 2022
2022 McLane Children's School Nurse Conference: The Well-Being Effect
Since the start of the pandemic, school nurses have worked tirelessly on the frontlines.
Category
Format
  • Conference / meeting
Credits
Event date June 14, 2022
Antibody tests for COVID-19
The SARS-CoV-2 virus caused a globally growing pandemic call coronavirus disease 2019 (COVID-19) that has disrupted  social, political, and medical environments around the world. Nations are assessing ways to reopen businesses while trying to balance health care risks and economic  fallouts. Strategies involving antibody testing have been proposed before phased reopening of the economy. Therefore, assessing the sensitivity and specificity of antibody tests for SARS-CoV-2 detect the presence of IgA, IgM, or IgG antibodies produced by B cells. Please click here to subscribe to BUMC Proceedings
Category
  • BUMC Proceedings
Format
  • Journal
Credits
  • American Board of Internal Medicine (ABIM) MOC Part 2
  • AMA PRA Category 1 Credit
  • Attendance
Advanced heart failure with reduced ejection fraction
Patients suffering advanced heart failure with reduced ejection fraction (HFrEF) account for a large portion of patients admitted to hospitals worldwide. Mortality and 30-day readmission rates for HFrEF are now a focus of value-based payment models, making management of this disease a priority for hospitals, physicians, and payers alike. Angiotensin-converting enzyme inhibitors have been the cornerstone of therapy for decades. However, with treatment, the prognosis for patients with advanced HFrEF remains poor. Fortunately, advances in medical therapy and mechanical support offer some patients improvement in both survival and quality of life. We review advances in short- and long-term mechanical support and explore changes to organ allocation for cardiac transplantation. In addition, we provide a guide to facilitate appropriate referral to an advanced heart failure team.
Category
  • BUMC Proceedings
Format
  • Journal
Credits
  • American Board of Internal Medicine (ABIM) MOC Part 2
  • AMA PRA Category 1 Credit
  • Attendance
Quality improvement initiative for pain management in primary care
In the context of both chronic pain and opioid crises, this large-system quality improvement project sought to increase use of evidence-based multimodal pain management strategies.  Primary care providers (PCPs) in internal medicine and family medicine identified as above- median prescribers of 3
Category
  • BUMC Proceedings
Format
  • Journal
Credits
  • American Board of Internal Medicine (ABIM) MOC Part 2
  • AMA PRA Category 1 Credit
  • Attendance
Role of endothelial cell receptors in the context of SARS-CoV-2 infections (COVID-19)
Endothelial cell (EC) dysfunction contributes to COVID-19–associated vascular inflammation and coagulopathy, and the angioten-sin-converting enzyme 2 (ACE2) receptor plays a role in EC dysfunction in COVID-19. To expand the understanding of the role of the ACE2 receptor relative to EC dysfunction, this review addresses (1) tissue distribution of the ACE2 protein and its mRNA expression in humans, (2) susceptibility of the capillary ECs to SARS-CoV-2 infection, and (3) the role of EC dysfunction relevant to ACE2 and nuclear factor-jB in COVID-19.
Category
  • BUMC Proceedings
Format
  • Journal
Credits
  • American Board of Internal Medicine (ABIM) MOC Part 2
  • AMA PRA Category 1 Credit
  • Attendance

Pages